The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
MicroRNA replacement therapy in cancer
Open accessAbstract
Despite the recent progress in cancer management approaches, the mortality rate of cancer is still growing and there are lots of challenges in the clinics in terms of novel therapeutics. MicroRNAs (miRNA) are regulatory small noncoding RNAs and are already confirmed to have a great role in regulating gene expression level by targeting multiple molecules that affect cell physiology and disease development. Recently, miRNAs have been introduced as promising therapeutic targets for cancer treatment. Regulatory potential of tumor suppressor miRNAs, which enables regulation of entire signaling networks within the cells, makes them an interesting option for developing cancer therapeutics. In this regard, over recent decades, scientists have aimed at developing powerful and safe targeting approaches to restore these suppressive miRNAs in cancerous cells. The present review summarizes the function of miRNAs in tumor development and presents recent findings on how miRNAs have served as therapeutic agents against cancer, with a special focus on tumor suppressor miRNAs (mimics). Moreover, the latest investigations on the therapeutic strategies of miRNA delivery have been presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Items 201–210 of 210
Łabieniec-Watała, M., Karolczak, K., Siewiera, K., & Watała, C. W. (2013) · Molecules · doi:10.3390/molecules181113769 · Cited by 23
Aptamer-Mediated Cancer Gene Therapy
Xiang, D., Shigdar, S. L., Qiao, G. G., Zhou, S., Li, Y., Wei, M. Q., Qiao, L., Shamaileh, H. A., Zhu, Y., Zheng, C., et al. (2015) · Current Gene Therapy · doi:10.2174/1566523214666141224095105 · Cited by 23
Lee, H. J., Namgung, R., Kim, W. J., Kim, J. I., & Park, I. (2013) · Macromolecular Research · doi:10.1007/s13233-013-1161-z · Cited by 22
Zhang, M., Matyunina, L. V., Walker, L. D., Chen, W., Xiao, H., Benigno, B. B., Wu, R., & McDonald, J. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-08502-z · Cited by 21
Ngankeu, A., Ranganathan, P., Havelange, V., Nicolet, D., Volinia, S., Powell, B. L., Kolitz, J. E., Uy, G. L., Stone, R. M., Kornblau, S. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23150 · Cited by 19
Biodegradable polymer nanocarriers for therapeutic antisense microRNA delivery in living animals
Paulmurugan, R., Sekar, N. M., & Sekar, T. V. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.914830 · Cited by 11
MicroRNA Based Therapeutic Strategies for Cancer: Emphasis on Advances in Renal Cell Carcinoma
Majid, S., & Dahiya, R. (2014) · Springer eBooks · doi:10.1007/978-3-319-05134-5_10 · Cited by 6
Guessous, F., Cruickshanks, N. A., Zhang, Y., Schiff, D., Sarkaria, J. N., & Abounader, R. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-345 · Cited by 1
Han, S., Belsare, S., Zhang, D., Beveridge, M. J., Rinaldi, C., Trevino, J. G., Schmittgen, T. D., & Hughes, S. J. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-4322 · Cited by 1
Kato, M., Kurozumi, A., Goto, Y., Nohata, N., Arai, T., Okato, A., Koshizuka, K., Kojima, S., Ichikawa, T., & Seki, N. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-1459 · Cited by 1
Cited by
miRNAs in Cancer (Review of Literature)
Smolarz, B., Durczyński, A., Romanowicz, H., Szyłło, K., & Hogendorf, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052805 · Cited by 296
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
MicroRNAs as regulators of brain function and targets for treatment of epilepsy
Brennan, G. P., & Henshall, D. C. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0369-8 · Cited by 169
Momin, M. Y., Gaddam, R. R., Kravitz, M., Gupta, A., & Vikram, A. (2021) · Cells · doi:10.3390/cells10113097 · Cited by 107
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Singh, S., Saini, H., Sharma, A., Gupta, S., Huddar, V. G., & Tripathi, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155254 · Cited by 25
Metadata
- Authors
- Mollaei, H., Safaralizadeh, R., & Rostami, Z.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-01-03
- Volume
- 234
- Issue
- 8
- Pages
- 12369-12384
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2907368400
- Cited by
- 262
- References
- 210
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.